Optimal success with Optibodies from NordicQC!

news July 24 2018

 

“The aim of Nordic immunohistochemical Quality Control (NordiQC) is to promote the quality of immunohistochemistry and expand its clinical use by arranging schemes for immunohistochemical proficiency testing and providing examples of recommended protocols, tissue controls and other relevant information including descriptions of epitopes and technical protocol parameters.”

We are proud to present the results from the last independent quality control where our OptibodiesTM below received optimal result!

OptibodiesTM are an an innovative highly optimised line of CE/IVD approved antibodies for use in pathology, developed at Nordic BioSite’s GLP certified laboratory, BioSiteHisto, based in Tampere, Finland. Read more

Rabbit monoclonal OptibodiesTM

• HER2 (BSR44) – Optimal
• PD-L1 (BSR90) – Optimal
• Calretinin (BSR235) – Optimal
• MSH6 (BSR100) – Optimal

Mouse monoclonal OptibodiesTM

• Synaptophysin (BS15) – Optimal

References:
1. http://www.nordiqc.org/about.php
2. http://www.nordiqc.org/news.php#news_19

Subscribe to our newsletter

Get the latest news within your area of research to your inbox.
Subscribe →